YABAO PHARMACEUTICAL GROUP CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.56 CNY | +1.23% |
|
+6.67% | -4.93% |
| Sales 2022 | 2.72B 375M 29.99B | Sales 2023 | 2.91B 402M 32.1B | Capitalization | 5.22B 720M 57.54B |
|---|---|---|---|---|---|
| Net income 2022 | 105M 14.5M 1.16B | Net income 2023 | 200M 27.62M 2.21B | EV / Sales 2022 | 1.58 x |
| Net cash position 2022 | 227M 31.33M 2.5B | Net cash position 2023 | 409M 56.44M 4.51B | EV / Sales 2023 | 1.65 x |
| P/E ratio 2022 |
43.3
x | P/E ratio 2023 |
26.4
x | Employees | 4,367 |
| Yield 2022 |
0.85% | Yield 2023 |
-
| Free-Float | 83.67% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.23% | ||
| 1 week | +6.67% | ||
| Current month | +5.64% | ||
| 1 month | +5.64% | ||
| 3 months | +5.98% | ||
| 6 months | -23.72% | ||
| Current year | -4.93% |
1 week
6.20
6.58
1 month
5.976.58
Current year
4.947.08
1 year
4.949.00
3 years
4.9411.90
5 years
4.5011.90
10 years
4.5019.50
| Managers | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 40 | 22/04/19 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 52 | - |
Wu Xian Ren
CHM | Chairman | 64 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 64 | - |
Zhen Jiang Xu
CHM | Chairman | 51 | 14/05/14 |
Peng Bo Ren
BRD | Director/Board Member | 51 | 10/03/07 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +1.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 6.56 | +1.23% | 21,240,280 |
| 29/04/24 | 6.48 | +0.78% | 21,163,160 |
| 26/04/24 | 6.43 | +1.58% | 26,524,180 |
| 25/04/24 | 6.33 | -0.31% | 12,043,810 |
| 24/04/24 | 6.35 | +2.09% | 18,197,120 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotes
YABAO PHARMACEUTICAL GROUP CO. LTD is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company mainly provides light pastes, tablets, injections, capsules, oral liquids, bulk drugs and other pharmaceutical products. The Company is also engaged in the wholesaling and trading of pharmaceuticals. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
16/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -4.93% | 640M | |
| +20.51% | 43.18B | |
| +20.67% | 22.59B | |
| +15.41% | 14.56B | |
| +43.55% | 11.5B | |
| -8.37% | 6.93B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +10.21% | 5.36B | |
| -2.27% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
